These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9301478)

  • 1. Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization.
    Kenyon BM; Browne F; D'Amato RJ
    Exp Eye Res; 1997 Jun; 64(6):971-8. PubMed ID: 9301478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalidomide inhibits corneal angiogenesis induced by vascular endothelial growth factor.
    Kruse FE; Joussen AM; Rohrschneider K; Becker MD; Völcker HE
    Graefes Arch Clin Exp Ophthalmol; 1998 Jun; 236(6):461-6. PubMed ID: 9646092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of thalidomide and structurally related compounds on corneal angiogenesis is comparable to their teratological potency.
    Joussen AM; Germann T; Kirchhof B
    Graefes Arch Clin Exp Ophthalmol; 1999 Dec; 237(12):952-61. PubMed ID: 10654163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination oral antiangiogenic therapy with thalidomide and sulindac inhibits tumour growth in rabbits.
    Verheul HM; Panigrahy D; Yuan J; D'Amato RJ
    Br J Cancer; 1999 Jan; 79(1):114-8. PubMed ID: 10408702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide is an inhibitor of angiogenesis.
    D'Amato RJ; Loughnan MS; Flynn E; Folkman J
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):4082-5. PubMed ID: 7513432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model of angiogenesis in the mouse cornea.
    Kenyon BM; Voest EE; Chen CC; Flynn E; Folkman J; D'Amato RJ
    Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1625-32. PubMed ID: 8675406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenic therapy of human esophageal cancers with thalidomide in nude mice.
    Kotoh T; Dhar DK; Masunaga R; Tabara H; Tachibana M; Kubota H; Kohno H; Nagasue N
    Surgery; 1999 May; 125(5):536-44. PubMed ID: 10330943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis).
    Azar DT
    Trans Am Ophthalmol Soc; 2006; 104():264-302. PubMed ID: 17471348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibitory effects of recombinant plasminogen kringle 1-3 on the neovascularization of rabbit cornea induced by angiogenin, bFGF, and VEGF.
    Kim JH; Kim JC; Shin SH; Chang SI; Lee HS; Chung SI
    Exp Mol Med; 1999 Dec; 31(4):203-9. PubMed ID: 10630375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
    Ma X; Ottino P; Bazan HE; Bazan NG
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization.
    Lai CM; Brankov M; Zaknich T; Lai YK; Shen WY; Constable IJ; Kovesdi I; Rakoczy PE
    Hum Gene Ther; 2001 Jul; 12(10):1299-310. PubMed ID: 11440623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibitory effect of thalidomide analogue on corneal neovascularization in rabbits.
    Lee YK; Chung SK
    Cornea; 2013 Aug; 32(8):1142-8. PubMed ID: 23739149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalidomide's chirality.
    Wnendt S; Zwingenberger K
    Nature; 1997 Jan; 385(6614):303-4. PubMed ID: 9002511
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea.
    Edelman JL; Castro MR; Wen Y
    Invest Ophthalmol Vis Sci; 1999 May; 40(6):1112-23. PubMed ID: 10235544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of thalidomide and 2 analogs on collagen induced arthritis.
    Oliver SJ; Cheng TP; Banquerigo ML; Brahn E
    J Rheumatol; 1998 May; 25(5):964-9. PubMed ID: 9598899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomide down-regulates the expression of VEGF and bFGF in cisplatin-resistant human lung carcinoma cells.
    Li X; Liu X; Wang J; Wang Z; Jiang W; Reed E; Zhang Y; Liu Y; Li QQ
    Anticancer Res; 2003; 23(3B):2481-7. PubMed ID: 12894531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of corneal neovascularization by rapamycin.
    Kwon YS; Kim JC
    Exp Mol Med; 2006 Apr; 38(2):173-9. PubMed ID: 16672771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of corneal angiogenesis by local application of vasostatin.
    Wu PC; Yang LC; Kuo HK; Huang CC; Tsai CL; Lin PR; Wu PC; Shin SJ; Tai MH
    Mol Vis; 2005 Jan; 11():28-35. PubMed ID: 15660022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide and a thalidomide analogue inhibit endothelial cell proliferation in vitro.
    Moreira AL; Friedlander DR; Shif B; Kaplan G; Zagzag D
    J Neurooncol; 1999 Jun; 43(2):109-14. PubMed ID: 10533722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis.
    Zheng M; Deshpande S; Lee S; Ferrara N; Rouse BT
    J Virol; 2001 Oct; 75(20):9828-35. PubMed ID: 11559816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.